Inicio
Información del autor
Autor Marcos Arango Barrientos
Comentario :
Médico Internista Hematólogo, Hospital Pablo Tobón Uribe
|
Documentos disponibles escritos por este autor (14)
Clasificado(s) por (Año de edición descendente) Refinar búsquedaCytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis / Marcos Arango Barrientos
Título : Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis Tipo de documento : documento electrónico Autores : Marcos Arango Barrientos, Fecha de publicación : 2021 Títulos uniformes : Bone Marrow Transplantation Idioma : Inglés (eng) Resumen : Haploidentical related donor transplantation (haplo-HCT) is associated with cytokine release syndrome (CRS). We conducted a multicenter retrospective study to analyze risk factors for CRS and outcomes after haplo-HCT. We included 451 patients from four academic centers receiving both peripheral blood and bone marrow grafts. Severe CRS was more common with PB vs. BM grafts (19.5% vs 4.9%, OR 2.9, p = 0.05). Multivariable analysis identified recipient CMV sero-positivity, prior transplant, HCT-CI score and donor–recipient sex mismatch as risk factors for severe CRS. Outcomes were analyzed with no CRS as the comparison group. Overall survival (OS) was superior with mild CRS (HR 0.64, p = 0.05) and worst with severe CRS (HR 2.12, p = 0.0038). Relapse risk was significantly decreased in both mild CRS (HR 0.38, p Mención de responsabilidad : Ramzi Abboud, Fei Wan, Jacopo Mariotti, Marcos Arango, Luca Castagna, Rizwan Romee, Mehdi Hamadani & Saurabh Chhabra Referencia : Bone Marrow Transplant. 2021 Nov;56(11):2763-2770. DOI (Digital Object Identifier) : 10.1038/s41409-021-01403-w PMID : 34262142 En línea : https://www.nature.com/articles/s41409-021-01403-w Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5810 Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis [documento electrónico] / Marcos Arango Barrientos, . - 2021.
Obra : Bone Marrow Transplantation
Idioma : Inglés (eng)
Resumen : Haploidentical related donor transplantation (haplo-HCT) is associated with cytokine release syndrome (CRS). We conducted a multicenter retrospective study to analyze risk factors for CRS and outcomes after haplo-HCT. We included 451 patients from four academic centers receiving both peripheral blood and bone marrow grafts. Severe CRS was more common with PB vs. BM grafts (19.5% vs 4.9%, OR 2.9, p = 0.05). Multivariable analysis identified recipient CMV sero-positivity, prior transplant, HCT-CI score and donor–recipient sex mismatch as risk factors for severe CRS. Outcomes were analyzed with no CRS as the comparison group. Overall survival (OS) was superior with mild CRS (HR 0.64, p = 0.05) and worst with severe CRS (HR 2.12, p = 0.0038). Relapse risk was significantly decreased in both mild CRS (HR 0.38, p Mención de responsabilidad : Ramzi Abboud, Fei Wan, Jacopo Mariotti, Marcos Arango, Luca Castagna, Rizwan Romee, Mehdi Hamadani & Saurabh Chhabra Referencia : Bone Marrow Transplant. 2021 Nov;56(11):2763-2770. DOI (Digital Object Identifier) : 10.1038/s41409-021-01403-w PMID : 34262142 En línea : https://www.nature.com/articles/s41409-021-01403-w Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5810 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001744 AC-2021-060 Archivo digital Producción Científica Artículos científicos Disponible
Título : Hemorrhagic cystitis after haploidentical transplantation with post-transplantation cyclophosphamide: protective effect of MESNA continuous infusion Tipo de documento : documento electrónico Autores : Marcos Arango Barrientos, Fecha de publicación : 2020 Títulos uniformes : Biology of Blood and Marrow Transplantation Idioma : Inglés (eng) Palabras clave : BK virus Cyclophosphamide Cystitis Haploidentical MESNA Transplantation Resumen : Hemorrhagic cystitis (HC) is an important complication after haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with post-transplantation cyclophosphamide (PT-CY). Sodium 2-mercaptoethanesulfonate (MESNA) can prevent bladder injury when given with PT-CY. However, the best way to deliver MESNA is not known. This study assessed the incidence of HC after haplo-HSCT with PT-CY with 2 different methods of MESNA administration. The cumulative incidence of HC was lower in patients who received MESNA as a continuous infusion compared with those who received it as an intermittent bolus (5.6% versus 27.8%; P = .01). MESNA administration as an infusion was associated with a lower risk of developing HC (hazard ratio [HR], .19; 95% confidence interval [CI], .04 to .86; P = .02) on univariate analysis. This effect remained significant after adjustment in multivariate analysis (HR, .21; 95% CI, .04 to .88; P = .03). MESNA delivered as a continuous infusion is a simple and potentially useful way to prevent HC after PT-CY. Mención de responsabilidad : Marcos Arango, Doris Cardona Referencia : Biol Blood Marrow Transplant. 2020 Aug;26(8):1492-1496 DOI (Digital Object Identifier) : 10.1016/j.bbmt.2020.04.028 PMID : 32417488 En línea : https://linkinghub.elsevier.com/retrieve/pii/S1083879120302834 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5119 Hemorrhagic cystitis after haploidentical transplantation with post-transplantation cyclophosphamide: protective effect of MESNA continuous infusion [documento electrónico] / Marcos Arango Barrientos, . - 2020.
Obra : Biology of Blood and Marrow Transplantation
Idioma : Inglés (eng)
Palabras clave : BK virus Cyclophosphamide Cystitis Haploidentical MESNA Transplantation Resumen : Hemorrhagic cystitis (HC) is an important complication after haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with post-transplantation cyclophosphamide (PT-CY). Sodium 2-mercaptoethanesulfonate (MESNA) can prevent bladder injury when given with PT-CY. However, the best way to deliver MESNA is not known. This study assessed the incidence of HC after haplo-HSCT with PT-CY with 2 different methods of MESNA administration. The cumulative incidence of HC was lower in patients who received MESNA as a continuous infusion compared with those who received it as an intermittent bolus (5.6% versus 27.8%; P = .01). MESNA administration as an infusion was associated with a lower risk of developing HC (hazard ratio [HR], .19; 95% confidence interval [CI], .04 to .86; P = .02) on univariate analysis. This effect remained significant after adjustment in multivariate analysis (HR, .21; 95% CI, .04 to .88; P = .03). MESNA delivered as a continuous infusion is a simple and potentially useful way to prevent HC after PT-CY. Mención de responsabilidad : Marcos Arango, Doris Cardona Referencia : Biol Blood Marrow Transplant. 2020 Aug;26(8):1492-1496 DOI (Digital Object Identifier) : 10.1016/j.bbmt.2020.04.028 PMID : 32417488 En línea : https://linkinghub.elsevier.com/retrieve/pii/S1083879120302834 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5119 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001376 AC-2020-054 Archivo digital Producción Científica Artículos científicos Disponible
Título : Measurable residual disease assessment and allogeneic transplantation as consolidation therapy in adult acute lymphoblastic leukemia in Colombia Tipo de documento : documento electrónico Autores : Marcos Arango Barrientos, ; Laura María Díaz Correa, Fecha de publicación : 2020 Títulos uniformes : Clinical Lymphoma, Myeloma & Leukemia Idioma : Inglés (eng) Palabras clave : Acute lymphoblastic leukemia Disease free survival Hematopoietic stem-cell transplantation Measurable residual disease Prognosis Resumen : Introduction: Detectable minimal residual disease (MRD) after therapy for acute lymphoblastic leukemia (ALL) is the strongest predictor of hematologic relapse. The objective of the study was to assess disease-free survival (DFS) and overall survival (OS) of patients with ALL according with MRD status at the end of induction therapy in a Colombian population. Patients and Methods: We assessed a retrospective cohort to compare DFS and OS in adults with de novo ALL according to MRD status at the end of induction chemotherapy, and the type of postinduction consolidation strategy used. Results: A total of 165 adults with ALL were included in the MRD part of the study, 73 patients in the MRD-negative group and 92 in the MRD-positive group. Median DFS for the MRD-positive group was 11 months (95% confidence interval, 11.7-22.2) and was not reached for the MRD-negative group ( P Mención de responsabilidad : Juan Felipe Combariza, Marcos Arango, Laura Díaz, Claudia Agudelo, Sonia Hernandez, Ana María Madera, Guillermo León, Vladimir Avila, Leonardo Bautista, Jaime Valdés, Rocio Orduz, Fabian Mejía, Liliana Moreno y Carlos Ramirez Referencia : Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):e365-e372. DOI (Digital Object Identifier) : 10.1016/j.clml.2020.11.010 PMID : 33277225 En línea : https://linkinghub.elsevier.com/retrieve/pii/S2152-2650(20)30634-0 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5187 Measurable residual disease assessment and allogeneic transplantation as consolidation therapy in adult acute lymphoblastic leukemia in Colombia [documento electrónico] / Marcos Arango Barrientos, ; Laura María Díaz Correa, . - 2020.
Obra : Clinical Lymphoma, Myeloma & Leukemia
Idioma : Inglés (eng)
Palabras clave : Acute lymphoblastic leukemia Disease free survival Hematopoietic stem-cell transplantation Measurable residual disease Prognosis Resumen : Introduction: Detectable minimal residual disease (MRD) after therapy for acute lymphoblastic leukemia (ALL) is the strongest predictor of hematologic relapse. The objective of the study was to assess disease-free survival (DFS) and overall survival (OS) of patients with ALL according with MRD status at the end of induction therapy in a Colombian population. Patients and Methods: We assessed a retrospective cohort to compare DFS and OS in adults with de novo ALL according to MRD status at the end of induction chemotherapy, and the type of postinduction consolidation strategy used. Results: A total of 165 adults with ALL were included in the MRD part of the study, 73 patients in the MRD-negative group and 92 in the MRD-positive group. Median DFS for the MRD-positive group was 11 months (95% confidence interval, 11.7-22.2) and was not reached for the MRD-negative group ( P Mención de responsabilidad : Juan Felipe Combariza, Marcos Arango, Laura Díaz, Claudia Agudelo, Sonia Hernandez, Ana María Madera, Guillermo León, Vladimir Avila, Leonardo Bautista, Jaime Valdés, Rocio Orduz, Fabian Mejía, Liliana Moreno y Carlos Ramirez Referencia : Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):e365-e372. DOI (Digital Object Identifier) : 10.1016/j.clml.2020.11.010 PMID : 33277225 En línea : https://linkinghub.elsevier.com/retrieve/pii/S2152-2650(20)30634-0 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5187 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001633 AC-2020-127 Archivo digital Producción Científica Artículos científicos Disponible
Título : Cost–effectiveness analysis of interventions for prevention of invasive aspergillosis among leukemia patients during hospital construction activities Tipo de documento : documento electrónico Autores : Marcos Arango Barrientos, ; Juan Felipe Combariza Vallejo, Fecha de publicación : 2018 Títulos uniformes : European Journal of Haematology Idioma : Inglés (eng) Palabras clave : Acute lymphoid leukemia acute myeloid leukemia aspergillosis high efficiency particulate absorption filters hospital design and construction Resumen : Objectives: Invasive Aspergillosis (IA) is a serious problem among hematological patients and it is associated with high mortality. This situation can worsen at times of hospital construction, however there are several preventive measures available. This work aims to define the cost-effectiveness of some of these interventions. Patients and methods: A decision tree model was used, it was divided into four arms according to each 1 of the interventions performed. A cost-effectiveness incremental analysis comparing environmental control measures, high efficiency particulate absorption (HEPA) filter installation and prophylaxis with posaconazole was done.Probabilistic and deterministic sensitivity analyses were also carried out. Results: Among 86 patients with 175 hospitalization episodes, the incidence of IA with environmental protection measures, antifungal prophylaxis and hospitalization in rooms with HEPA filters was 14.4%, 6.3% and 0%, respectively. An Incremental Cost Effectiveness Ratio analysis was performed and it was found that HEPA filtered rooms and environmental protection measures are cost saving interventions when compared with posaconazole prophylaxis (−$2665 vs −$4073 vs $42 531 US dollars, respectively) for IA episode prevented. Conclusion: The isolation of inpatients with acute leukemia during hospital construction periods in HEPA filtered rooms could reduce the incidence of IA and might be a cost-effective prevention strategy. Mención de responsabilidad : Juan F Combariza, Luis F Toro, John J Orozco, Marcos Arango Referencia : Eur J Haematol. 2018 Feb;100(2):140-146. DOI (Digital Object Identifier) : 10.1111/ejh.12991 PMID : 29105850 En línea : https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.12991 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4106 Cost–effectiveness analysis of interventions for prevention of invasive aspergillosis among leukemia patients during hospital construction activities [documento electrónico] / Marcos Arango Barrientos, ; Juan Felipe Combariza Vallejo, . - 2018.
Obra : European Journal of Haematology
Idioma : Inglés (eng)
Palabras clave : Acute lymphoid leukemia acute myeloid leukemia aspergillosis high efficiency particulate absorption filters hospital design and construction Resumen : Objectives: Invasive Aspergillosis (IA) is a serious problem among hematological patients and it is associated with high mortality. This situation can worsen at times of hospital construction, however there are several preventive measures available. This work aims to define the cost-effectiveness of some of these interventions. Patients and methods: A decision tree model was used, it was divided into four arms according to each 1 of the interventions performed. A cost-effectiveness incremental analysis comparing environmental control measures, high efficiency particulate absorption (HEPA) filter installation and prophylaxis with posaconazole was done.Probabilistic and deterministic sensitivity analyses were also carried out. Results: Among 86 patients with 175 hospitalization episodes, the incidence of IA with environmental protection measures, antifungal prophylaxis and hospitalization in rooms with HEPA filters was 14.4%, 6.3% and 0%, respectively. An Incremental Cost Effectiveness Ratio analysis was performed and it was found that HEPA filtered rooms and environmental protection measures are cost saving interventions when compared with posaconazole prophylaxis (−$2665 vs −$4073 vs $42 531 US dollars, respectively) for IA episode prevented. Conclusion: The isolation of inpatients with acute leukemia during hospital construction periods in HEPA filtered rooms could reduce the incidence of IA and might be a cost-effective prevention strategy. Mención de responsabilidad : Juan F Combariza, Luis F Toro, John J Orozco, Marcos Arango Referencia : Eur J Haematol. 2018 Feb;100(2):140-146. DOI (Digital Object Identifier) : 10.1111/ejh.12991 PMID : 29105850 En línea : https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.12991 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4106 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000717 AC-2018-004 Archivo digital Producción Científica Artículos científicos Disponible 
Título : Successful treatment of heparin-induced thrombocytopenia with apixaban in a patient with chronic kidney disease requiring hemodialysis Tipo de documento : documento electrónico Autores : Juan David Ramírez Quintero, ; Marcos Arango Barrientos, Fecha de publicación : 2018 Títulos uniformes : Clinical Case Reports Idioma : Inglés (eng) Palabras clave : Apixaban hemodialysis heparin thrombocytopenia thrombosis Resumen : Heparin‐induced thrombocytopenia (HIT) is a prothrombotic state that can affect patients with chronic kidney disease (CKD) on hemodialysis (HD). This case highlights the potential usefulness of apixaban therapy for patients with HIT and CKD on HD. Mención de responsabilidad : Daniela Trujillo Agudelo, Juan D Ramirez Quintero, Marcos Arango Barrientos Referencia : Clin Case Rep. 2018 Sep 25;6(11):2147-2149. DOI (Digital Object Identifier) : 10.1002/ccr3.1817 PMID : 30455909 Derechos de uso : CC BY-NC En línea : https://onlinelibrary.wiley.com/doi/full/10.1002/ccr3.1817 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4166 Successful treatment of heparin-induced thrombocytopenia with apixaban in a patient with chronic kidney disease requiring hemodialysis [documento electrónico] / Juan David Ramírez Quintero, ; Marcos Arango Barrientos, . - 2018.
Obra : Clinical Case Reports
Idioma : Inglés (eng)
Palabras clave : Apixaban hemodialysis heparin thrombocytopenia thrombosis Resumen : Heparin‐induced thrombocytopenia (HIT) is a prothrombotic state that can affect patients with chronic kidney disease (CKD) on hemodialysis (HD). This case highlights the potential usefulness of apixaban therapy for patients with HIT and CKD on HD. Mención de responsabilidad : Daniela Trujillo Agudelo, Juan D Ramirez Quintero, Marcos Arango Barrientos Referencia : Clin Case Rep. 2018 Sep 25;6(11):2147-2149. DOI (Digital Object Identifier) : 10.1002/ccr3.1817 PMID : 30455909 Derechos de uso : CC BY-NC En línea : https://onlinelibrary.wiley.com/doi/full/10.1002/ccr3.1817 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4166 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000780 AC-2018-067 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
2018-067.pdfAdobe Acrobat PDF
